Exploratory Study in Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases

NCT01834014 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Liver Metastasis
Colorectal Cancer

Interventions

DRUG: Bevacizumab
DRUG: Cetuximab
DRUG: L-OHP
DRUG: l-LV
DRUG: 5-FU
DRUG: 5-FU

Sponsor

EPS Corporation